FDA Label for Sitagliptin And Metformin Hydrochloride
View Indications, Usage & Precautions
Sitagliptin And Metformin Hydrochloride Product Label
The following document was submitted to the FDA by the labeler of this product Zydus Lifesciences Limited. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Other
Package Label.Principal Display Panel
NDC 70771-1886-6
Sitagliptin and metformin hydrochloride extended-release tablets for oral use
50 mg/500 mg
60 Tablets
Rx only
NDC 70771-1887-6
Sitagliptin and metformin hydrochloride extended-release tablets for oral use
50 mg/1000 mg
60 Tablets
Rx only
NDC 70771-1888-3
Sitagliptin and metformin hydrochloride extended-release tablets for oral use
100 mg/1000 mg
30 Tablets
Rx only
* Please review the disclaimer below.
